|
The Center for Healthcare Supply Chain Research’s Board of Directors is composed of healthcare’s most respected leaders, who serve as experts advancing the Center’s mission and ensuring its financial stability.
The Center’s Board of Directors is composed of 12 members. Terms of office are three years, and members may serve up to two consecutive terms.
Robert W. Belknap
Chairman of the Board
Executive Director, Trade Sales & Operations
Boehringer Ingelheim Pharmaceuticals, Inc.
Antonio "Tony" Pera
Vice Chairman of the Board
Senior Vice President, Supply Chain Management
AmerisourceBergen Company
Rolando DeCardenas
Vice President, General Manager, Oncology Rx
US Oncology Specialty, LP
Larry Doud
Chief Executive Officer
RDC-Rochester Drug Cooperative, Inc.
Steve Harper
Senior Director of Channel Strategy and Management
Genentech USA
John Harrington
Chief Commercial Officer, Global Oncology
sanofi-aventis U.S.
Jeffrey Herzfeld
Senior Vice President & General Manager
TEVA Pharmaceuticals USA
Hal Korman
President, North America
Mylan Pharmaceuticals, Inc.
Jim Scott
Senior Vice President, Branded Purchasing
Cardinal Health, Inc.
Luis Valcarcel
Trade Accounts Director, Strategic Business Group
Ortho McNeil-Janssen Pharmaceutical Services
Mark Walchirk
President, McKesson Specialty Care Solutions
McKesson Coorporation
Jeff Watson
EVP Chief Commercial Officer, N.A, Apotex Inc. & COO Apotex Corp, U.S.A.
Apotex Corp.
John M. Gray
President, Center for Healthcare Supply Chain Research
President & CEO, HDMA
Karen J. Ribler
Executive Vice President & COO
Center for Healthcare Supply Chain Research
Ann Bittman
Secretary/Treasurer, Center for Healthcare Supply Chain Research
Executive Vice President & COO, HDMA
Arthur Y. Tsien, Esq.
Olsson, Frank and Weeda, P.C.
Anti-trust Policy
Anti-harassment Policy
|
